In8Bio (INAB) Total Current Liabilities (2020 - 2026)
In8Bio's Total Current Liabilities was $2.25 million in Q2 2026, up 15.4% from $1.95 million a year earlier and up 4.4% from the prior quarter.
In8Bio (INAB) Total Current Liabilities (2020 - 2026) Analysis & Trends
At the end of FY2025, Total Current Liabilities at In8Bio came in at $3.16 million, up 2.5% from FY2024.
- Total Current Liabilities shows a five-year compound annual growth rate of 4.2% (FY2020 to FY2025).
- In earlier years, Total Current Liabilities was $3.08 million in FY2024 (-42.8%), $5.39 million in FY2023 (-7.4%), $5.82 million in FY2022 (+158.1%) and $2.26 million in FY2021 (-12.3%).
- Quarterly Total Current Liabilities has moved between $1.7 million (Q3 2025) and $5.82 million (Q4 2022) over five years.
- Compared with a year earlier, Total Current Liabilities was higher in two of the last seven quarters, with an average decline of 26.6%.
- The best year-over-year quarter for Total Current Liabilities over five years was Q4 2022 (growth of 158.1%); the worst was Q2 2025 (a decline of 58.9%).
- Per Business Quant data, INAB's Total Current Liabilities in the three quarters before Q2 2026 was $2.16 million (Q1 2026), $3.16 million (Q4 2025) and $1.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 47.74 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 55.46 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 41.64 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 27.73 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 31.75 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 31.55 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 25.50 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 11.02 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 32.65 Bn |
| 10 | In8Bio | 20.44 Mn | -57.91 Mn | - | 2.25 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.25 Mn |
| Mar 31, 2026 | 2.16 Mn |
| Dec 31, 2025 | 3.16 Mn |
| Sep 30, 2025 | 1.70 Mn |
| Jun 30, 2025 | 1.95 Mn |
| Mar 31, 2025 | 2.96 Mn |
| Dec 31, 2024 | 3.08 Mn |
| Sep 30, 2024 | 3.64 Mn |
| Jun 30, 2024 | 4.76 Mn |
| Dec 31, 2023 | 5.39 Mn |
| Sep 30, 2023 | 4.69 Mn |
| Jun 30, 2023 | 3.78 Mn |
| Mar 31, 2023 | 3.75 Mn |
| Dec 31, 2022 | 5.82 Mn |
| Sep 30, 2022 | 4.90 Mn |
| Jun 30, 2022 | 2.97 Mn |
| Mar 31, 2022 | 2.07 Mn |
| Dec 31, 2021 | 2.26 Mn |
| Sep 30, 2021 | 2.16 Mn |
| Jun 30, 2021 | 2.77 Mn |
In8Bio Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=INAB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "INAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=INAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();